Meet Us at Pharmacology 2024, 10–12 December 2024, Harrogate, UK
Conference: Pharmacology 2024
Date: 10–12 December 2024
Location: Harrogate, UK
MDPI will be attending Pharmacology 2024 as an exhibitor. We welcome researchers from different backgrounds to visit and share their latest ideas with us.
The British Pharmacological Society is a charity and global membership community whose mission is to promote and advance the whole spectrum of pharmacology. It leads the way in pharmacology research and application around the world, with around 4,000 members from more than 60 countries. Each year, the British Pharmacological Society hosts its annual Pharmacology conference, gathering individuals from academia, healthcare, industry, and the regulatory sector to share and celebrate the latest research and developments in this field and other related areas. This conference is a great opportunity for those studying and working in this field to attend lectures from experts and emerging researchers, network, socialize, and showcase their own work.
If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://www.miceconciergeme.com/pharmacology-2024.
The following MDPI journals will be represented:
- Pharmaceuticals;
- Pharmacoepidemiology;
- Pharmacy;
- Antioxidants;
- Neurology International;
- Future Pharmacology;
- BioTech;
- Cancers;
- Sci. Pharm.;
- Sclerosis;
- Medicines;
- JPM;
- DDC.
The year 2024 marks the 20th anniversary of Pharmaceuticals (ISSN: 1424-8247), a peer-reviewed open access journal on medicinal chemistry and related drug sciences, published monthly online by MDPI. With an Impact Factor of 4.3 and a CiteScore of 6.1, the journal is covered in Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus/SciFinder, and other databases. The journal has published more than 6000 papers from more than 37,000 authors. More than 10,000 reviewers have reviewed the journal at least once. We value the contributions made by our editors, authors, and reviewers.